Nephros Inc
$ 3.88
2.92%
24 Feb - close price
- Market Cap 41,231,500 USD
- Current Price $ 3.88
- High / Low $ 4.00 / 3.77
- Stock P/E 27.71
- Book Value 0.94
- EPS 0.14
- Next Earning Report 2026-03-23
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.16 %
- 52 Week High 6.42
- 52 Week Low 1.39
About
Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.
Analyst Target Price
$7.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-03-05 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-07 | 2023-11-08 | 2023-08-09 | 2023-05-10 | 2023-03-08 |
| Reported EPS | 0.03 | 0.02 | 0.05 | 0.03 | 0.02 | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 | -0.03 | -0.1 |
| Estimated EPS | -0.02 | -0.01 | -0.005 | -0.015 | -0.02 | -0.01 | -0.04 | -0.02 | -0.06 | -0.05 | -0.02 | -0.06 |
| Surprise | 0.05 | 0.03 | 0.055 | 0.045 | 0.04 | -0.02 | 0.02 | -0.04 | 0.04 | 0.01 | -0.01 | -0.04 |
| Surprise Percentage | 250% | 300% | 1100% | 300% | 200% | -200% | 50% | -200% | 66.6667% | 20% | -50% | -66.6667% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-23 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NEPH
2026-02-16 08:57:36
Nephros Inc., a water technology company, is expanding into Puerto Rico to provide point-of-use water filtration systems for healthcare, foodservice, and hospitality sectors. The company estimates this market opportunity to be $10 million, driven by concerns over waterborne pathogens and infrastructure challenges. Nephros will offer comprehensive services including installation, filter replacement, and customer support in Spanish, addressing the need for high-quality filtration in critical environments.
2026-02-13 16:57:36
Nephros, Inc. has announced its expansion into the Puerto Rican market with its advanced water filtration solutions, targeting high-need applications in medical and commercial sectors. The company aims to address unmet needs for premium filtration services, particularly against waterborne pathogens and contaminants. Nephros will differentiate itself through rapid response, local-language support, and on-site services, projecting a $10 million market opportunity across healthcare, foodservice, and hospitality.
2026-02-13 13:27:40
Nephros, Inc. (Nasdaq: NEPH) has announced its entry into the Puerto Rican market to provide water filtration solutions for medical and commercial sectors, including healthcare, foodservice, and hospitality. The company targets high-need applications and estimates a $10 million market opportunity in the region, which it believes is underserved by premium filtration providers. Nephros plans to differentiate itself through rapid response, on-site services, and local-language support to address critical water safety needs.
2026-02-10 23:51:45
Nephros, Inc. has announced its expansion into the Puerto Rican market to provide advanced water filtration solutions for medical and commercial sectors. The company aims to address unmet needs in infection control and water purity, estimating a $10 million market opportunity across healthcare, foodservice, and hospitality. Nephros will differentiate itself through rapid service, local support, and point-of-use filtration for microbial control and contaminant removal.
2026-02-07 04:29:11
Nephros, Inc. (NASDAQ:NEPH) shareholders have seen their stock price drop 28% in the last month, despite a 150% gain over the past year. The company's P/S ratio of 2.3x is similar to the broader Machinery industry, but analysts forecast significantly lower revenue growth for Nephros compared to the industry average. This disparity suggests that investors might be overlooking potential risks or overvaluing the company based on current sentiment rather than future growth prospects.
2026-02-06 10:31:51
Nephros, Inc.'s stock has dropped 28% in the last month, despite a 150% gain over the past year. The company's P/S ratio of 2.3x is in line with the industry average, but its projected revenue growth of 13% for the next year is significantly lower than the industry forecast of 20%. This disparity raises questions about whether the current P/S ratio is sustainable given the weaker growth outlook.
